Long-term Depletion of Histamine in Guinea-pigs by Administration of Alpha-fluoromethylhistidine, a Specific Inhibitor of Histidine Decarboxylase; Effect on the Sensitivity of Histamine Receptors

Overview

Journal Agents Actions

Specialty Pharmacology

Date 1988 Jun 1

PMID 3136625

Citations 1

Authors

H Fukuda

K Maeyama

Y Ito

T Watanabe

H Wada

Affiliations

Soon will be listed here.

Abstract

The effect of intraperitoneal administration of alpha-fluoromethylhistidine (alpha-FMH), a specific inhibitor of histidine decarboxylase, at a dose of 100 mg/kg twice a day for 6 weeks on the sensitivity of histamine receptors in the guinea-pigs was examined. The histamine contents in the ileum, heart and brain after the treatment decreased to about 54%, 83% and 9-62% (depending on the region), respectively, of those of controls. However, there were no significant difference in the histamine-induced contraction of the ileum and atrium, the maximal binding (Bmax) and the dissociation constant (Kd) of [3H]-mepyramine binding to membrane fractions of the ileum and brain (except the cortex) and the increase of cyclic AMP formation induced by histamine in membranes of the heart and brain (except the cortex) between alpha-FMH-treated- and untreated animals. These results suggest that long-term histamine depletion dose not significantly affect the sensitivity of histamine receptors of guinea-pig except in the brain cortex.

Citing Articles

Histamine receptors in the central nervous system.

Timmerman H Pharm Weekbl Sci. 1989; 11(5):146-50.

PMID: 2687795 DOI: 10.1007/BF01959461.

References

Slotkin T, Slepetis R, Weigel S, Whitmore W . Effects of alpha-fluoromethylhistidine (FMH), an irreversible inhibitor of histidine decarboxylase, on development of brain histamine and catecholamine systems in the neonatal rat. Life Sci. 1983; 32(25):2897-903. DOI: 10.1016/0024-3205(83)90326-0. View

Hegstrand L, Kanof P, Greengard P . Histamine-sensitive adenylate cyclase in mammalian brain. Nature. 1976; 260(5547):163-5. DOI: 10.1038/260163a0. View

Watanabe T, Kitamura Y, Maeyama K, Go S, Yamatodani A, Wada H . Absence of increase of histidine decarboxylase activity in mast cell-deficient W/W mouse embryos before parturition. Proc Natl Acad Sci U S A. 1981; 78(7):4209-12. PMC: 319758. DOI: 10.1073/pnas.78.7.4209. View

Bartholeyns J, Bouclier M . Effect of alpha-monofluoromethyl histidine, an irreversible inhibitor of histidine decarboxylase, on gestation in mice. Contraception. 1982; 26(5):535-42. DOI: 10.1016/0010-7824(82)90152-4. View

Friedhoff A, Bonnet K, Tosengarten H . Reversal of two manifestations of dopamine receptor supersensitivity by administration of L-dopa. Res Commun Chem Pathol Pharmacol. 1977; 16(3):411-23. View

Bouclier M, Jung M, Gerhart F . alpha-Fluoromethyl histidine. Inhibition of histidine decarboxylase in pylorus ligated rat. Biochem Pharmacol. 1983; 32(10):1553-6. DOI: 10.1016/0006-2952(83)90326-x. View

Maeyama K, Watanabe T, Yamatodani A, Taguchi Y, Kambe H, Wada H . Effect of alpha-fluoromethylhistidine on the histamine content of the brain of W/Wv mice devoid of mast cells: turnover of brain histamine. J Neurochem. 1983; 41(1):128-34. DOI: 10.1111/j.1471-4159.1983.tb11823.x. View

Slotkin T, Bartolome J, Whitmore W . Developmental effects of alpha-fluoromethylhistidine, an irreversible inhibitor of histidine decarboxylase, on growth and on levels and turnover of catecholamines. Life Sci. 1983; 33(21):2137-45. DOI: 10.1016/0024-3205(83)90338-7. View

DUGGAN D, Hooke K, Maycock A . Inhibition of histamine synthesis in vitro and in vivo by S-alpha-fluoromethylhistidine. Biochem Pharmacol. 1984; 33(24):4003-9. DOI: 10.1016/0006-2952(84)90013-3. View

10.

Garbarg M, Barbin G, Rodergas E, Schwartz J . Inhibition of histamine synthesis in brain by alpha-fluoromethylhistidine, a new irreversible inhibitor: in vitro and in vivo studies. J Neurochem. 1980; 35(5):1045-52. DOI: 10.1111/j.1471-4159.1980.tb07858.x. View

11.

Gray E, Whittaker V . The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation. J Anat. 1962; 96:79-88. PMC: 1244174. View

12.

KOLLONITSCH J, Perkins L, PATCHETT A, Doldouras G, Marburg S, DUGGAN D . Selective inhibitors of biosynthesis of aminergic neurotransmitters. Nature. 1978; 274(5674):906-8. DOI: 10.1038/274906a0. View

13.

GOSSELIN R, GOSSELIN R . Tachyphylaxis of guinea-pig ileum to histamine and furtrethonium. J Pharmacol Exp Ther. 1973; 184(2):494-505. View

14.

Bielkiewicz B, Cook D . The mechanism of the histamine-induced desensitization of guinea-pig ileum. Gen Pharmacol. 1984; 15(1):51-4. DOI: 10.1016/0306-3623(84)90080-6. View

15.

Pycock C, Dawbarn D, OShaughnessy C . Behavioural and biochemical changes following chronic administration of L-dopa to rats. Eur J Pharmacol. 1982; 79(3-4):201-15. DOI: 10.1016/0014-2999(82)90626-4. View

16.

PAPAVASILIOU P, Miller S, Thal L, Nerder L, Houlihan G, Rao S . Age-related motor and catecholamine alterations in mice on levodopa supplemented diet. Life Sci. 1981; 28(26):2945-52. DOI: 10.1016/0024-3205(81)90271-x. View

17.

Tung A, Blake J, Roman I, Vlasses P, Ferguson R, Zweerink H . In vivo and in vitro inhibition of human histidine decarboxylase by (S)-alpha-fluoromethylhistidine. Biochem Pharmacol. 1985; 34(19):3509-15. DOI: 10.1016/0006-2952(85)90725-7. View

18.

Yamatodani A, Maeyama K, Watanabe T, Wada H, Kitamura Y . Tissue distribution of histamine in a mutant mouse deficient in mast cells: clear evidence for the presence of non-mast-cell histamine. Biochem Pharmacol. 1982; 31(3):305-9. DOI: 10.1016/0006-2952(82)90175-7. View

19.

Maeyama K, Watanabe T, Taguchi Y, Yamatodani A, Wada H . Effect of alpha-fluoromethylhistidine, a suicide inhibitor of histidine decarboxylase, on histamine levels in mouse tissues. Biochem Pharmacol. 1982; 31(14):2367-70. DOI: 10.1016/0006-2952(82)90531-7. View

20.

DALE H, Laidlaw P . The physiological action of beta-iminazolylethylamine. J Physiol. 1910; 41(5):318-44. PMC: 1512903. DOI: 10.1113/jphysiol.1910.sp001406. View